✦ LIBER ✦

Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease

✍ Scribed by Devillier, Raynier; Fürst, Sabine; El-Cheikh, Jean; Castagna, Luca; Harbi, Samia; Granata, Angela; Crocchiolo, Roberto; Oudin, Claire; Mohty, Bilal; Bouabdallah, Reda; Chabannon, Christian; Stoppa, Anne-Marie; Charbonnier, Aude; Broussais-Guillaumot, Florence; Calmels, Boris; Lemarie, Claude; Rey, Jèrôme; Vey, Norbert; Blaise, Didier

Book ID: 122977105
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 409 KB
Volume: 20
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.11.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two days of antithymocyte globulin are a

Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases

✍ Crocchiolo, Roberto; Esterni, Benjamin; Castagna, Luca; Fürst, Sabine; El-Cheikh 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 665 KB

Lower dose of antithymocyte globulin doe

Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplant

✍ Salem, Galena; Ruppert, Amy S.; Elder, Patrick; Hofmeister, Craig C.; Benson, Do 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 628 KB

Infectious complications in chronic graf

Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens

✍ S. Yamasaki; Y. Heike; S. Mori; T. Fukuda; D. Maruyama; R. Kato; E. Usui; K. Koi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Five Versus 2.5 mg/kg of Anti-Thymocyte-

Five Versus 2.5 mg/kg of Anti-Thymocyte-Globulin Dose in Reduced-Intensity-Conditioning Reduces Acute and Chronic Graft-Versus-Host Disease for Patients with Myeloid Malignancies Undergoing Allogeneic Stem Cell Transplantation

✍ R. Devillier; R. Crocchiolo; L. Castagna; S. Fürst; J. El Cheikh; C. Faucher; T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB